Skip to main navigation
Skip to content
About Us
Menu Toggle
About Us
Management Team
Board of Directors
Medical Advisory Board
Scientific Advisory Board
Investors
Pipeline
Menu Toggle
Pipeline
Alzheimer’s Disease
Synucleinopathies
Dry Age-Related Macular Degeneration
For Patients and Their Families
Publications
Resources
Clinical Trials
Menu Toggle
Clinical Trials
Menu Toggle
SEQUEL Study
SHIMMER Study
START Study
Resources
Conversations
Contracting Ops
Main Menu
About Us
Menu Toggle
About Us
Management Team
Board of Directors
Medical Advisory Board
Scientific Advisory Board
Investors
Pipeline
Menu Toggle
Pipeline
Alzheimer’s Disease
Synucleinopathies
Dry Age-Related Macular Degeneration
For Patients and Their Families
Publications
Resources
Clinical Trials
Menu Toggle
Clinical Trials
Menu Toggle
SEQUEL Study
SHIMMER Study
START Study
Resources
Conversations
Contracting Ops
About Us
Menu Toggle
About Us
Management Team
Board of Directors
Medical Advisory Board
Scientific Advisory Board
Investors
Pipeline
Menu Toggle
Pipeline
Alzheimer’s Disease
Synucleinopathies
Dry Age-Related Macular Degeneration
For Patients and Their Families
Publications
Resources
Clinical Trials
Menu Toggle
Clinical Trials
Menu Toggle
SEQUEL Study
SHIMMER Study
START Study
Resources
Conversations
Contracting Ops
Main Menu
About Us
Menu Toggle
About Us
Management Team
Board of Directors
Medical Advisory Board
Scientific Advisory Board
Investors
Pipeline
Menu Toggle
Pipeline
Alzheimer’s Disease
Synucleinopathies
Dry Age-Related Macular Degeneration
For Patients and Their Families
Publications
Resources
Clinical Trials
Menu Toggle
Clinical Trials
Menu Toggle
SEQUEL Study
SHIMMER Study
START Study
Resources
Conversations
Contracting Ops
Event Details
Overview
News & Events
Press Releases
Events & Presentations
Financial Information
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Historical Price Lookup
Analyst Coverage
Corporate Governance
Documents and Charters
Management Team
Board of Directors
Committee Composition
Shareholder Resources
Investor FAQs
Email Alerts
Contact IR
RSS Feeds
AD/PD™ 2024 Alzheimer's & Parkinson's Diseases Conference
Mar 5 - Mar 9, 2024
Scroll to Top